PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 14 filers reported holding PTC THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $9,677,487,000 | -13.6% | 9,300,000 | -17.7% | 0.01% | -30.0% |
| Q4 2018 | $11,200,153,000 | -14.8% | 11,300,000 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $13,148,003,000 | +4.0% | 11,300,000 | -11.7% | 0.01% | 0.0% |
| Q2 2018 | $12,647,487,000 | +7.3% | 12,800,000 | 0.0% | 0.01% | +11.1% |
| Q1 2018 | $11,782,707,000 | +3.2% | 12,800,000 | -13.5% | 0.01% | -10.0% |
| Q4 2017 | $11,418,792,000 | -3.9% | 14,800,000 | 0.0% | 0.01% | -9.1% |
| Q3 2017 | $11,879,960,000 | -3.0% | 14,800,000 | -6.3% | 0.01% | -8.3% |
| Q2 2017 | $12,250,372,000 | +20.2% | 15,800,000 | 0.0% | 0.01% | +20.0% |
| Q1 2017 | $10,191,632,000 | +98094.7% | 15,800,000 | -6.0% | 0.01% | -16.7% |
| Q4 2016 | $10,379,000 | +10.6% | 16,800,000 | 0.0% | 0.01% | +20.0% |
| Q3 2016 | $9,385,000 | – | 16,800,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 8,067,000 | $8,071,000 | 7.78% |
| DeepCurrents Investment Group LLC | 5,000,000 | $4,975,000 | 0.62% |
| WOLVERINE ASSET MANAGEMENT LLC | 27,439,000 | $27,337,000 | 0.33% |
| CSS LLC/IL | 3,000,000 | $2,993,000 | 0.20% |
| FARALLON CAPITAL MANAGEMENT LLC | 24,130,000 | $23,602,000 | 0.17% |
| Allianz Asset Management GmbH | 30,570,000 | $30,097,000 | 0.03% |
| CREDIT SUISSE AG/ | 12,105,000 | $12,029,000 | 0.01% |
| JANUS HENDERSON GROUP PLC | 15,498,000 | $15,401,000 | 0.01% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 11,300,000 | $11,200,153,000 | 0.01% |
| AMERIPRISE FINANCIAL INC | 12,700,000 | $12,621,000 | 0.01% |